Evidence map›Paper›PMID 26856755›Full record

ArticleScientific reports2016

RNF135, RING finger protein, promotes the proliferation of human glioblastoma cells in vivo and in vitro via the ERK pathway.

Yongjian Liu, Feng Wang, Yongsheng Liu, Yiqun Yao, Xiupeng Lv, Bin Dong, Jun Li, Siyang Ren, Yiwen Yao, Yinghui Xu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Upregulation ofGenes · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yongjian LiuDepartment of Interventional therapy, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Feng WangDepartment of Interventional therapy, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Yongsheng LiuDepartment of Interventional therapy, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Yiqun YaoDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Xiupeng LvDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Bin DongDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Jun LiDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Siyang RenDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Yiwen YaoDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Yinghui XuDepartment of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People's Republic of China.
Dalian Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ring finger protein 135 (RNF135), located on chromosome 17q11.2, is a RING finger domain-containing E3 ubiquitin ligase that was identified as a bio-marker and therapy target of glioblastoma. In our study, we confirmed that RNF135 was up-regulated in glioblastoma tissues compared with normal brain (NB) tissues, and that RNF135 knockdown inhibited proliferation and migration and led to cell cycle arrest in the G0/G1 phase in vivo. By lowering RNF135 expression, phosphorylated Erk and cell cycle protein CDK4 were down-regulated, while p27(Kip1) and p21(Waf1/Cip1) were up-regulated in U87 and U251 cells in vitro. In addition, using the immunofluorescence double labelling method, we found that RNF135 and P-Erk were co-localized in the cytoplasm and were highly expressed in glioblastoma samples compared with NB tissues. Moreover, the growth of U87 cell-transplanted tumours in nude mice was inhibited while transduced with Lv-shRNF135. Taken together, our findings demonstrate the biological effects of RNF135 in glioblastoma cell proliferation, migration and cell cycle, and its role in the progression of glioblastoma may be associated with the ERK signal transduction pathway.

Indexed as

Cell ProliferationMAP Kinase Signaling SystemAnimalsBrain NeoplasmsCell Line, TumorCyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27FemaleGlioblastomaHumansMiceMice, Inbred BALB CMice, NudeUbiquitin-Protein LigasesCDK4 protein, humanCDKN1A protein, humanCDKN1B protein, humanCyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27RNF135 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID26856755
PMCPMC4746631
OpenAlexW2414907820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.